PRF Technologies Ltd. PRFX
Regular-session close
After hours · Nov 19, 4:00 PM ET
- YTD
- -80.58%
- 1 year
- -85.90%
5D -0.0660 (-9.24%)
- Market cap
- 2.18M
- EPS (ttm)
- -4.09
- Shares out
- 874.86K
- Forward P/E
- -0.37
- YTD return
- -80.58%
- 1-year return
- -85.90%
- 50-day average
- 1.84
- Volume
- 28.61K
- Avg volume
- 228.89K
- Open
- 0.6313
- Previous close
- 0.6479
- Day's range
- 0.6076 – 0.6399
- 52-week range
- 0.604 – 7.95
- Beta
- 0.56
Key statistics
- 200-day average
- 3.57
- Enterprise value
- 339.62K
- Free cash flow
- -4.93M
- Total cash
- 2.78M
- Total debt
- 59.00K
- Return on equity
- -716.67%
- Short % of float
- 9.08%
Fundamental scorecard
5 of 25 checks passed on PRFX’s reported financials
5of 25 checks passed
- Value 1 of 5
- Growth 1 of 5
- Profitability 0 of 5
- Financial health 3 of 5
- Dividend 0 of 5
Statements to Jun 30, 2026.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 15, 2024 | Jun 1, 2024 | 0.00 | -9.60 | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | -65.27 | — | — |
| Feb 29, 2024 | Dec 1, 2023 | 0.00 | — | — | — |
| Nov 15, 2023 | Sep 1, 2023 | 0.00 | 11.52 | — | — |
| May 15, 2023 | Mar 1, 2023 | 0.00 | -52.79 | — | — |
| Mar 16, 2023 | Dec 1, 2022 | 0.00 | -69.59 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 24, 2024 | Maxim Group | down | Buy | Hold |
| Jun 26, 2024 | Maxim Group | reit | Buy | Buy |
About PRF Technologies Ltd.
PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and second trial for pain treatment of hernia repair operations. The company was incorporated in 2007 and is based in Tel Aviv, Israel.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Israel
- Website
- painreform.com
News
PRF Technologies Receives Nasdaq Delisting Determination Regarding Minimum Bid Price Requirement and Requests a Hearing PRF Technologies Strikes Non-Binding Term Sheet With Dotz Nano To Expand Dotz's Footprint In AI-Driven Energy Optimization Market; Dotz Agrees To Acquire PRF's DeepSolar/GridFeed AI Energy Platform For $1M
12 Health Care Stocks Moving In Friday's After-Market Session PRF Technologies Reports Cash Of ~$11M As Of Sept. 30; Plans To Initiate Enrollment In Its U.S. Multi-Center Clinical Study Of OcuRing-K; Intendws To Estabish GridFeed vAs Standalone Subsidiary
Your note
Sign in to keep a note on PRFX — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| UBS Group AG | 0.74% | 6,496 | 28.97K | Sep 29, 2024 |
| Two Sigma Securities, LLC | 0.49% | 4,308 | 19.21K | Sep 29, 2024 |
| HRT Financial LP | 0.41% | 3,577 | 15.95K | Sep 29, 2024 |
| Osaic Holdings Inc | 0.02% | 192 | 856 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.01% | 80 | 356 | Sep 29, 2024 |
